Showing results (161-170 of 227) with videos related to

Sort By:
Pageof 23
Biomedicines|January 8, 2025
Fecal Nervonic Acid as a Biomarker for Diagnosing and Monitoring Inflammatory Bowel DiseaseClaudia Kunst, Tanja Elger, Johanna Loibl, et al.
Biochimica Et Biophysica Acta|August 30, 2016
Ceramide and polyunsaturated phospholipids are strongly reduced in human hepatocellular carcinomaSabrina Krautbauer, Elisabeth M Meier, Lisa Rein-Fischboeck, et al.
International Journal of Molecular Sciences|August 23, 2016
Chemokine-Like Receptor 1 mRNA Weakly Correlates with Non-Alcoholic Steatohepatitis Score in Male but Not Female IndividualsMaximilian Neumann, Elisabeth M Meier, Lisa Rein-Fischboeck, et al.
Pathophysiology : the Official Journal of the International Society for Pathophysiology|April 23, 2025
Cholesteryl Ester Species but Not Serum Proprotein Convertase Subtilisin/Kexin Type 9 Levels Decline in Male Patients with Active Inflammatory Bowel DiseaseAngelika Hettenbach, Tanja Elger, Muriel Huss, et al.
Cancers|October 17, 2020
Chemerin Is Induced in Non-Alcoholic Fatty Liver Disease and Hepatitis B-Related Hepatocellular CarcinomaElisabeth M Haberl, Susanne Feder, Rebekka Pohl, et al.
International Journal of Molecular Sciences|May 14, 2025
Fecal Arachidonic Acid: A Potential Biomarker for Inflammatory Bowel Disease SeverityMuriel Huss, Tanja Elger, Claudia Kunst, et al.
Biochemical and Biophysical Research Communications|October 7, 2006
Aldehyde oxidase 1 is highly abundant in hepatic steatosis and is downregulated by adiponectin and fenofibric acid in hepatocytes in vitroMarkus Neumeier, Johanna Weigert, Andreas Schäffler, et al.
Inflammatory Bowel Diseases|June 16, 2006
Profiling adipocytokine secretion from creeping fat in Crohn's diseaseGisela Paul, Andreas Schäffler, Markus Neumeier, et al.
Metabolites|June 25, 2014
Adiponectin isoforms differentially affect gene expression and the lipidome of primary human hepatocytesJosef Wanninger, Gerhard Liebisch, Kristina Eisinger, et al.
Infectious Disease Reports|July 25, 2024
Proprotein Convertase Subtilisin/Kexin Type 9 Induction in COVID-19 Is Poorly Associated with Disease Severity and Cholesterol LevelsPatricia Mester, Pablo Amend, Stephan Schmid, et al.
Pageof 23